Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.19.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenues $ 5,411,443 $ 4,482,775
Operating expenses:    
Cost of product sales 1,947,892 863,624
Research and development 3,401,189 1,649,778
General and administrative 2,716,983 2,918,916
Sales and marketing 3,108,902 1,524,816
Amortization expense 1,078,847 1,017,408
Change in fair value of contingent consideration 180,402 262,769
Total operating expenses 12,434,215 8,237,311
Loss from operations (7,022,772) (3,754,536)
Other (expense) income:    
Change in fair value of warrant liability and unit purchase option liability (47,577) (23,251)
Other (expense) income, net (9,400) 18,655
Interest expense, net (207,941) (100,402)
Total other expense, net (264,918) (104,998)
Net loss before taxes (7,287,690) (3,859,534)
Income tax expense 166,358 23,313
Net loss $ (7,454,048) $ (3,882,847)
Common stock    
Other (expense) income:    
Net loss per share, basic and diluted (in dollars per share) $ (0.13) $ (0.12)
Preferred Stock    
Other (expense) income:    
Net loss per share, basic and diluted (in dollars per share) $ (0.67) $ 0.00
Product revenue, net    
Revenues $ 5,411,443 $ 4,260,119
Sales force revenue    
Revenues $ 0 $ 222,656